Correlation Between Arrowhead Pharmaceuticals and Stratasys

Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and Stratasys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and Stratasys into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arrowhead Pharmaceuticals and Stratasys, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and Stratasys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of Stratasys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and Stratasys.

Diversification Opportunities for Arrowhead Pharmaceuticals and Stratasys

0.4

Correlation Coefficient

Arrowhead Pharmaceuticals  Stratasys

Very weak diversification

The 3 months correlation between Arrowhead and Stratasys is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and Stratasys in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stratasys and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with Stratasys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stratasys has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and Stratasys go up and down completely randomly.

Pair Corralation between Arrowhead Pharmaceuticals and Stratasys

Given the investment horizon of 90 days Arrowhead Pharmaceuticals is expected to generate 1.18 times less return on investment than Stratasys. In addition to that, Arrowhead Pharmaceuticals is 1.08 times more volatile than Stratasys. It trades about 0.05 of its total potential returns per unit of risk. Stratasys is currently generating about 0.06 per unit of volatility. If you would invest  773.00  in Stratasys on October 5, 2024 and sell it today you would earn a total of  97.00  from holding Stratasys or generate 12.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Arrowhead Pharmaceuticals  vs.  Stratasys

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Stratasys

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Stratasys are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Stratasys unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Arrowhead Pharmaceuticals and Stratasys

The main advantage of trading using opposite Arrowhead Pharmaceuticals and Stratasys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, Stratasys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stratasys will offset losses from the drop in Stratasys' long position.

The idea behind Arrowhead Pharmaceuticals and Stratasys pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.